In older men, an invitation for comprehensive CV screening did not reduce death at 5.6 y

Area of Science:

• Cardiovascular Medicine
• Vascular Surgery
• Public Health Screening

Background:

• Abdominal aortic aneurysm (AAA) is a life-threatening condition.
• Screening programs aim to detect AAA early for timely intervention.
• The long-term impact of population-based AAA screening requires further investigation.

Purpose of the Study:

• To evaluate the 5-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial.
• To determine the effect of ultrasound screening for abdominal aortic aneurysm on all-cause and cardiovascular mortality in men aged 65-74 years.

Main Methods:

• A randomized controlled trial involving men aged 65-74 years.
• Participants were assigned to either an ultrasound screening group or a no-screening control group.
• Outcomes were assessed over a 5-year follow-up period.

Main Results:

• No significant difference in all-cause mortality between the screening and control groups.
• No significant difference in cardiovascular mortality between the groups.
• The study reported on rupture rates and surgical repair outcomes.

Conclusions:

• Population-based screening for abdominal aortic aneurysm in men aged 65-74 does not significantly reduce mortality after 5 years.
• The findings suggest a need to re-evaluate current screening guidelines for AAA.
• Further research may explore alternative screening strategies or target populations.